Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/25882

Title: Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice.
Authors: Van der Speeten, Kurt
Lemoine, Lieselotte
Sugarbaker, Paul
Issue Date: 2017
Citation: Pleura and Peritoneum, 2(2), p. 63-72
Abstract: Peritoneal surface malignancy (PSM) is a common manifestation of digestive and gynecologic malignancies alike. At present, patients with isolated PSM are treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The combination of CRS and intraperitoneal (IP) chemotherapy should now be considered standard of care for PSM from appendiceal epithelial cancers, colorectal cancer and peritoneal mesothelioma. Although there is a near universal standardization regarding the CRS, we are still lacking a much-needed standardization among the various IP chemotherapy treatment modalities used today in clinical practice. Pharmacologic evidence should be generated to answer important questions raised by the myriad of variables associated with IP chemotherapy.
URI: http://hdl.handle.net/1942/25882
DOI: 10.1515/pp-2017-0003
ISSN: 2364-768X
Category: A2
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
Published version - Main article875.97 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.